Dimachkie, Mazen M et al "Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease." Neurology (2022): 10.1212/WNL.0000000000200746. Web. 17 Aug. 2022.